Diomics reports $1.1 million investment round


diomicsDiomics raised $1.1 million as part of a fully subscribed non-brokered equity offering. The subscription, which started on April 15th, lured five investors. No offering was previously initiated by the company under a registration exemption with the SEC.

The company commercializes a technology platform, called Diomat, which picks up biologic materials from a variety of surfaces and release the majority of the DNA from the sample into an extraction solution with little or no sample retained with the capture matrix. The company developed its first product, the X-Swab, designed for forensic and diagnostic applications.

The company, headquartered in Carlsbad CA, is led by John Steel (President and CEO). Diomics elected to keep its revenues undisclosed.
The board of directors includes James Woodcock, Kevin Butler, Kirk Avery, Paul Buss and William Ballard.

Offering recap
Status: Completed
Company: Diomics
Industry: Biotechnology
Amount offered: $1.1 million
Amount placed: $1.1 million
First sale: 04-15-2014
Data as of: 04-21-2014

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s